Actively Recruiting
Electroporation for Cancer Treatment Real World Registry
Led by Mirai Medical · Updated on 2025-01-29
1000
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.
CONDITIONS
Official Title
Electroporation for Cancer Treatment Real World Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any patient who has been treated using Calcium Electroporation
- Any patient who has been treated using Electrochemotherapy
- Patients must be mentally capable of understanding the information given
- Patients must give written informed consent.
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal London Hospital
London, United Kingdom, E1 1FR
Actively Recruiting
Research Team
S
SEAN H KINSELLA
CONTACT
D
Declan Soden
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here